Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Neuralstem (CUR)

Neuralstem Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CUR
DateTimeSourceHeadlineSymbolCompany
19/03/202117:15GlobeNewswire Inc.NeuroRx Announces Dosing of First Patient with ZYESAMIâ„¢ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...NASDAQ:CURNeuralstem Inc
02/09/202013:00PR Newswire (US)Letter from Seneca Biopharma's Executive ChairmanNASDAQ:CURNeuralstem Inc
27/05/202016:00PR Newswire (US)Seneca Biopharma Announces the Closing of its $5 Million Registered Direct OfferingNASDAQ:CURNeuralstem Inc
04/11/201921:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
31/10/201915:00PR Newswire (US)Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCANASDAQ:CURNeuralstem Inc
30/10/201911:00PR Newswire (US)Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...NASDAQ:CURNeuralstem Inc
30/10/201910:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
29/10/201903:24PR Newswire (US)Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership SummitNASDAQ:CURNeuralstem Inc
28/10/201913:00PR Newswire (US)Neuralstem Becomes Seneca BiopharmaNASDAQ:CURNeuralstem Inc
12/10/201900:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
12/10/201900:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CURNeuralstem Inc
12/10/201900:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
12/10/201900:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
12/10/201900:26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
12/10/201900:24Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
03/10/201914:31PR Newswire (US)Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)NASDAQ:CURNeuralstem Inc
24/09/201921:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
24/09/201912:30PR Newswire (US)Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...NASDAQ:CURNeuralstem Inc
17/09/201922:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
14/08/201919:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
14/08/201912:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CURNeuralstem Inc
14/08/201912:30PR Newswire (US)Neuralstem Reports Second Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
09/08/201914:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CURNeuralstem Inc
07/08/201914:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
07/08/201912:30PR Newswire (US)Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued ListingNASDAQ:CURNeuralstem Inc
31/07/201912:30PR Newswire (US)Neuralstem Closes $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
29/07/201921:47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CURNeuralstem Inc
26/07/201911:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CURNeuralstem Inc
26/07/201903:40PR Newswire (US)Neuralstem Announces Pricing of $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
25/07/201911:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:CURNeuralstem Inc
 Showing the most relevant articles for your search:NASDAQ:CUR